drugset / Trial / NCT06535009
Study of ONO-7914 Alone and in Combination With ONO-4538 in Patients With Solid Tumors
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study is dose escalation study to evaluate the tolerability and safety of ONO-7914 alone and in combination with ONO-4538 in patients with advanced or metastatic solid tumors
Timeline
- Start
- 2022-02-08
- Primary completion
- 2025-02-26
- Completion
- 2025-02-26
Outcome
Outcome not reported
Stopped (Business): “Due to strategic reasons”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nivolumab | Monoclonal antibody | — | — |
| Subject | ONO-7914 | Unknown | — | — |